The mechanism behind the protective effects against NAFLD of the nutraceutical complex may upregulate the relative expression of TBC1D1 protein and downregulate the relative expression of ACACA, ACSL1 and FBP2 proteins. The gene discussed is ACACA; the disease is metabolic dysfunction-associated steatotic liver disease.